RESUMEN
OBJECTIVE: To investigate whether S100A8 is actively involved in matrix metalloproteinase (MMP)-mediated chondrocyte activation. METHODS: S100A8 and S100A9 proteins were detected in inflamed knee joints from mice with various forms of murine arthritis, using immunolocalization. Murine chondrocyte cell line H4 was stimulated with proinflammatory cytokines or recombinant S100A8. Messenger RNA (mRNA) and protein levels were measured using reverse transcriptase-polymerase chain reaction and intracellular fluorescence-activated cell sorting (FACS). Breakdown of aggrecan on the pericellular surface of the chondrocytes was measured using VDIPEN and NITEGE antibodies and FACS, and breakdown in patellar cartilage was measured by immunolocalization. RESULTS: S100A8 and S100A9 proteins were abundantly expressed in and around chondrocytes in inflamed knee joints after induction of antigen-induced arthritis or onset of spontaneous arthritis in interleukin-1 (IL-1) receptor antagonist-knockout mice. Stimulation of chondrocytes by the proinflammatory cytokines tumor necrosis factor alpha, IL-1beta, IL-17, and interferon-gamma caused strong up-regulation of S100A8 mRNA and protein levels and up-regulation to a lesser extent of S100A9 levels. Stimulation of chondrocytes with S100A8 induced significant up-regulation of MMP-2, MMP-3, MMP-9, MMP-13, ADAMTS-4, and ADAMTS-5 mRNA levels (up-regulated 4, 4, 3, 16, 8, and 4 times, respectively). VDIPEN and NITEGE neoepitopes were significantly elevated in a concentration-dependent manner in chondrocytes treated with 0.2, 1, or 5 microg/ml of S100A8. (VDIPEN levels were elevated 17%, 67%, and 108%, respectively, and NITEGE levels were elevated 8%, 33%, and 67%, respectively.) S100A8 significantly increased the effect of IL-1beta on MMP-3, MMP-13, and ADAMTS-5. Mouse patellae incubated with both IL-1beta and S100A8 had elevated levels of NITEGE within the cartilage matrix when compared with patellae incubated with IL-1beta or S100A8 alone. CONCLUSION: These findings indicate that S100A8 and S100A9 are found in and around chondrocytes in experimental arthritis. S100A8 up-regulates and activates MMPs and aggrecanase-mediated pericellular matrix degradation.
Asunto(s)
Artritis Experimental/patología , Cartílago/patología , Condrocitos/efectos de los fármacos , Condrocitos/patología , Proteínas S100/inmunología , Animales , Artritis Experimental/inmunología , Artritis Reumatoide/inmunología , Artritis Reumatoide/patología , Calgranulina A , Calgranulina B/genética , Calgranulina B/inmunología , Cartílago/inmunología , Condrocitos/inmunología , Humanos , Proteína Antagonista del Receptor de Interleucina 1/genética , Interleucina-6/metabolismo , Metaloproteinasas de la Matriz/genética , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , FN-kappa B/metabolismo , Polisacáridos/metabolismo , Proteínas S100/genética , Regulación hacia Arriba/inmunologíaRESUMEN
We recently showed that a class of novel carboxylated N:-glycans was constitutively expressed on endothelial cells. Activated, but not resting, neutrophils expressed binding sites for the novel glycans. We also showed that a mAb against these novel glycans (mAbGB3.1) inhibited leukocyte extravasation in a murine model of peritoneal inflammation. To identify molecules that mediated these interactions, we isolated binding proteins from bovine lung by their differential affinity for carboxylated or neutralized glycans. Two leukocyte calcium-binding proteins that bound in a carboxylate-dependent manner were identified as S100A8 and annexin I. An intact N terminus of annexin I and heteromeric assembly of S100A8 with S100A9 (another member of the S100 family) appeared necessary for this interaction. A mAb to S100A9 blocked neutrophil binding to immobilized carboxylated glycans. Purified human S100A8/A9 complex and recombinant human annexin I showed carboxylate-dependent binding to immobilized bovine lung carboxylated glycans and recognized a subset of mannose-labeled endothelial glycoproteins immunoprecipitated by mAbGB3.1. Saturable binding of S100A8/A9 complex to endothelial cells was also blocked by mAbGB3.1. These results suggest that the carboxylated glycans play important roles in leukocyte trafficking by interacting with proteins known to modulate extravasation.
Asunto(s)
Ácidos Carboxílicos/metabolismo , Proteínas Portadoras/metabolismo , Movimiento Celular , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Leucocitos/metabolismo , Polisacáridos/metabolismo , Secuencia de Aminoácidos , Animales , Anexina A1/química , Anexina A1/inmunología , Anexina A1/metabolismo , Anticuerpos Monoclonales/metabolismo , Anticuerpos Monoclonales/farmacología , Antígenos de Diferenciación/inmunología , Antígenos de Diferenciación/aislamiento & purificación , Antígenos de Diferenciación/metabolismo , Antígenos de Diferenciación/fisiología , Sitios de Unión de Anticuerpos , Unión Competitiva/inmunología , Proteínas de Unión al Calcio/inmunología , Proteínas de Unión al Calcio/aislamiento & purificación , Proteínas de Unión al Calcio/metabolismo , Proteínas de Unión al Calcio/fisiología , Calgranulina A , Calgranulina B , Proteínas Portadoras/aislamiento & purificación , Proteínas Portadoras/fisiología , Bovinos , Adhesión Celular/inmunología , Membrana Celular/inmunología , Membrana Celular/metabolismo , Movimiento Celular/inmunología , Cromatografía de Afinidad/métodos , Endotelio Vascular/inmunología , Glicopéptidos/síntesis química , Glicopéptidos/metabolismo , Humanos , Sueros Inmunes/metabolismo , Sueros Inmunes/farmacología , Leucocitos/inmunología , Pulmón/citología , Pulmón/inmunología , Pulmón/metabolismo , Ratones , Datos de Secuencia Molecular , Peso Molecular , Neutrófilos/inmunología , Neutrófilos/metabolismo , Conejos , Proteínas S100/inmunología , Proteínas S100/aislamiento & purificación , Proteínas S100/metabolismo , Proteínas S100/fisiología , Homología de Secuencia de AminoácidoRESUMEN
We previously reported an unusual carboxylated modification on N:-glycans isolated from whole bovine lung. We have now raised IgG mAbs against the modification by immunization with biotinylated aminopyridine-derivatized glycans enriched for the anionic species and screening for Abs whose reactivities were abrogated by carboxylate neutralization of bovine lung glycopeptides. One such Ab (mAb GB3.1) was inhibited by carboxylated bovine lung glycopeptides and other multicarboxylated molecules, but not by glycopeptides in which the carboxylate groups were modified. The Ab recognized an epitope constitutively expressed on bovine, human, and other mammalian endothelial cells. Stimulated, but not resting, neutrophils bound to immobilized bovine lung glycopeptides in a carboxylate-dependent manner. The binding of activated neutrophils to immobilized bovine lung glycopeptides was inhibited both by mAb GB3.1 and by soluble glycopeptides in a carboxylate-dependent manner. The Ab also inhibited extravasation of neutrophils and monocytes in a murine model of peritoneal inflammation. This inhibition of cell trafficking correlated with the increased sequestration but reduced transmigration of leukocytes that were found to be adherent to the endothelium of the mesenteric microvasculature. Taken together, these results indicate that these novel carboxylated N:-glycans are constitutively expressed on vascular endothelium and participate in acute inflammatory responses by interaction with activated neutrophils.
Asunto(s)
Adyuvantes Inmunológicos/fisiología , Anticuerpos Monoclonales , Endotelio Vascular/inmunología , Endotelio Vascular/patología , Activación Neutrófila/inmunología , Oligosacáridos/inmunología , Peritonitis/patología , Peritonitis/prevención & control , Enfermedad Aguda , Adyuvantes Inmunológicos/metabolismo , Amidohidrolasas/inmunología , Amidohidrolasas/metabolismo , Aminopiridinas/síntesis química , Aminopiridinas/inmunología , Animales , Aniones , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/metabolismo , Especificidad de Anticuerpos , Reacciones Antígeno-Anticuerpo , Sitios de Unión de Anticuerpos , Biotina/análogos & derivados , Biotina/síntesis química , Biotina/inmunología , Biotina/fisiología , Ácidos Carboxílicos/metabolismo , Bovinos , Movimiento Celular/inmunología , Células Cultivadas , Modelos Animales de Enfermedad , Endotelio Vascular/enzimología , Endotelio Vascular/metabolismo , Epítopos/inmunología , Epítopos/metabolismo , Femenino , Humanos , Inyecciones Intravenosas , Ratones , Ratones Endogámicos BALB C , Monocitos/patología , Neutrófilos/inmunología , Neutrófilos/metabolismo , Neutrófilos/patología , Oligosacáridos/metabolismo , Oligosacáridos/fisiología , Especificidad de Órganos/inmunología , Péptido-N4-(N-acetil-beta-glucosaminil) Asparagina Amidasa , Peritonitis/inmunología , Peritonitis/metabolismoRESUMEN
Intestinal biopsy in a boy with gastroenteritis-induced protein-losing enteropathy (PLE) showed loss of heparan sulfate (HS) and syndecan-1 core protein from the basolateral surface of the enterocytes, which improved after PLE subsided. Isoelectric focusing analysis of serum transferrin indicated a congenital disorder of glycosylation (CDG) and subsequent analysis showed three point mutations in the ALG6 gene encoding an alpha1,3-glucosyltransferase needed for the addition of the first glucose to the dolichol-linked oligosaccharide. The maternal mutation, C998T, causing an A333V substitution, has been shown to cause CDG-Ic, whereas the two paternal mutations, T391C (Y131H) and C924A (S308R) have not previously been reported. The mutations were tested for their ability to rescue faulty N:-linked glycosylation of carboxypeptidase Y in an ALG6-deficient Saccharomyces cerevisiae strain. Normal human ALG6 rescues glycosylation and A333V partially rescues, whereas the combined paternal mutations (Y131H and S308R) are ineffective. Underglycosylation resulting from each of these mutations is much more severe in rapidly dividing yeast. Similarly, incomplete protein glycosylation in the patient is most severe in rapidly dividing enterocytes during gastroenteritis-induced stress. Incomplete N:-linked glycosylation of an HS core protein and/or other biosynthetic enzymes may explain the selective localized loss of HS and PLE.
Asunto(s)
Enterocitos/metabolismo , Heparitina Sulfato/metabolismo , Mucosa Intestinal/metabolismo , Proteínas de la Membrana , Enteropatías Perdedoras de Proteínas/congénito , Enteropatías Perdedoras de Proteínas/metabolismo , Biopsia , Carboxipeptidasas/metabolismo , Fibroblastos/metabolismo , Glucosiltransferasas/deficiencia , Glicosilación , Histocitoquímica , Humanos , Inmunohistoquímica , Lactante , Mucosa Intestinal/patología , Masculino , Enteropatías Perdedoras de Proteínas/patología , Saccharomyces cerevisiae/metabolismoRESUMEN
Congenital disorders of glycosylation (CDGs) are metabolic deficiencies in glycoprotein biosynthesis that usually cause severe mental and psychomotor retardation. Different forms of CDGs can be recognized by altered isoelectric focusing (IEF) patterns of serum transferrin (Tf). Two patients with these symptoms and similar abnormal Tf IEF patterns were analyzed by metabolic labeling of fibroblasts with ¿2-(3)Hmannose. The patients produced a truncated dolichol-linked precursor oligosaccharide with 5 mannose residues, instead of the normal precursor with 9 mannose residues. Addition of 250 microM mannose to the culture medium corrected the size of the truncated oligosaccharide. Microsomes from fibroblasts of these patients were approximately 95% deficient in dolichol-phosphate-mannose (Dol-P-Man) synthase activity, with an apparent K(m) for GDP-Man approximately 6-fold higher than normal. DPM1, the gene coding for the catalytic subunit of Dol-P-Man synthase, was altered in both patients. One patient had a point mutation, C(274)G, causing an R(92)G change in the coding sequence. The other patient also had the C(274)G mutation and a 13-bp deletion that presumably resulted in an unstable transcript. Defects in DPM1 define a new glycosylation disorder, CDG-Ie.
Asunto(s)
Trastornos Congénitos de Glicosilación/enzimología , Trastornos Congénitos de Glicosilación/genética , Manosiltransferasas/deficiencia , Manosiltransferasas/genética , Mutación , Encefalopatías Metabólicas Innatas/diagnóstico , Encefalopatías Metabólicas Innatas/enzimología , Encefalopatías Metabólicas Innatas/etiología , Secuencia de Carbohidratos , Células Cultivadas , Trastornos Congénitos de Glicosilación/complicaciones , Trastornos Congénitos de Glicosilación/diagnóstico , Análisis Mutacional de ADN , Discapacidades del Desarrollo/diagnóstico , Femenino , Fibroblastos/citología , Fibroblastos/enzimología , Glicósido Hidrolasas/metabolismo , Glicosilación , Humanos , Lactante , Focalización Isoeléctrica , Isoenzimas/deficiencia , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Manosa/metabolismo , Manosiltransferasas/metabolismo , Microcefalia/diagnóstico , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Convulsiones/diagnóstico , Eliminación de Secuencia , Transferrina/metabolismoAsunto(s)
Trastornos Congénitos de Glicosilación/diagnóstico , Trastornos Congénitos de Glicosilación/terapia , Manosa/metabolismo , Trastornos Congénitos de Glicosilación/genética , Genes Recesivos/genética , Glicosilación , Humanos , Focalización Isoeléctrica/métodos , Manosa/uso terapéutico , Hipotonía Muscular/diagnóstico , Mutación/genética , Oligosacáridos/biosíntesis , Oligosacáridos/química , Trastornos Psicomotores/diagnóstico , TransferrinaRESUMEN
We describe a simple, noninvasive, and effective therapy for leukocyte adhesion deficiency type II (LAD II), a rare inherited disorder of fucose metabolism. This disorder leads to an immunodeficiency caused by the absence of carbohydrate-based selectin ligands on the surface of neutrophils as well as to severe psychomotor and mental retardation. The fucosylation defect in LAD II fibroblasts can be corrected by addition of L-fucose to the culture medium. This prompted us to initiate dietary fucose therapy on a patient with LAD II. Oral supplementation of fucose in this patient induced the expression of fucosylated selectin ligands on neutrophils and core fucosylation of serum glycoproteins. During 9 months of treatment, infections and fever disappeared, elevated neutrophil counts returned to normal, and psychomotor capabilities improved.
Asunto(s)
Fucosa/administración & dosificación , Síndrome de Deficiencia de Adhesión del Leucocito/tratamiento farmacológico , Administración Oral , Fucosa/uso terapéutico , Humanos , Síndrome de Deficiencia de Adhesión del Leucocito/metabolismo , Ligandos , Selectinas/metabolismoRESUMEN
Three antibodies that recognize distinct fucose epitopes were used to study fucosylation during growth and development of Dictyostelium discoideum. mAb83.5 is known to recognize an undefined "fucose epitope" on several proteins with serine-rich domains, while mAb CAB4, and a component of anti-horse-radish peroxidase, specifically recognize Fucalpha1,6GlcNAc and Fucalpha1,3GlcNAc residues respectively in the core of N-linked oligosaccharides. We show that mAb 83.5 defines a new type of O-glycosylation. Serine-containing peptides incubated with GDPbeta[3H]Fuc and microsomes formed two fucosylated products. A neutral product accounting for 30% of the label did not react with the antibody, while the rest of the label was incorporated into a charged product which contained all the mAb83.5 reactive material. beta-Elimination of the labeled peptide or endogenous products produced [3H]Fuc-1-P, indicating phosphodiester linkage to serine. Fucbeta-1-P and GDP-betaFuc at 100 microM blocked mAb83.5 binding to endogenous and peptide products, but their alpha-linked anomers did not. Electrospray ionization mass spectra of the neutral and anionic labeled products showed major peaks of mass units corresponding to O-Fuc-Ser peptide and O-Fuc-phospho-Ser peptide, respectively. The activity of Fuc-phosphotransferase exactly paralleled the accumulation of reactive glycans during growth and development. The expressions of N-glycan core Fucalpha1,6GlcNAc and Fucalpha1,3GlcNAc and their respective fucosyl transferase activities were also synchronous, but their developmental regulation differed from one another. Fucalpha1, 6GlcNAc was expressed maximally during growth but declined during development. In contrast core Fucalpha1,3GlcNAc epitopes were expressed almost exclusively during development. These findings provide direct evidence for a novel type of O-phosphofucosylation, demonstrate the existence of an O-fucosyl transferase, and identify two different types of core fucosylation in the N-glycans of Dictyostelium.
Asunto(s)
Dictyostelium/metabolismo , Fucosa/metabolismo , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/inmunología , Dictyostelium/enzimología , Dictyostelium/crecimiento & desarrollo , Ensayo de Inmunoadsorción Enzimática , Epítopos/inmunología , Fucosa/análogos & derivados , Fucosa/inmunología , Fucosiltransferasas/metabolismo , Glicosilación , HumanosRESUMEN
Core fucosylation of N-linked oligosaccharides (GlcNAcbeta1, 4(Fucalpha1,6)GlcNAcbeta1-Asn) is a common modification in animal glycans, but little is known about the distribution of core-fucosylated glycoproteins in mammalian tissues. Two monoclonal antibodies, CAB2 and CAB4, previously raised against carbohydrate epitopes of Dictyostelium discoideum glycoproteins (Crandall, I. E. and Newell, P. C. (1989) Development 107, 87-94), specifically recognize fucose residues in alpha1,6-linkage to the asparagine-bound GlcNAc of N-linked oligosaccharides. These IgG3 antibodies do not cross-react with glycoproteins containing alpha-fucoses in other linkages commonly seen in N- or O-linked sugar chains. CAB4 recognizes core alpha1,6 fucose regardless of terminal sugars, branching pattern, sialic acid linkage, or polylactosamine substitution. This contrasts to lentil and pea lectins that recognize a similar epitope in only a subset of these structures. Additional GlcNAc residues found in the core of N-glycans from dominant Chinese hamster ovary cell mutants LEC14 and LEC18 progressively decrease binding. These antibodies show that many proteins in human tissues are core-fucosylated, but their expression is localized to skin keratinocytes, vascular and visceral smooth muscle cells, epithelia, and some extracellular matrix-like material surrounding subpopulations of lymphocytes. The availability of these antibodies now allows for an extended investigation of core fucose epitope expression in development and malignancy and in genetically manipulated mice.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Dictyostelium/inmunología , Fucosa/inmunología , Glicoproteínas/inmunología , Inmunoglobulina G/inmunología , Polisacáridos/inmunología , Animales , Western Blotting , Conformación de Carbohidratos , Secuencia de Carbohidratos , Cricetinae , Ensayo de Inmunoadsorción Enzimática , Mapeo Epitopo , Eritropoyetina/metabolismo , Glicoconjugados/inmunología , Humanos , Antígenos del Grupo Sanguíneo de Lewis/inmunología , Ratones , Datos de Secuencia Molecular , Fosfolipasas A/metabolismoRESUMEN
4-Methylumbelliferyl-beta-xyloside (Xyl beta MU) primes glycosaminoglycan synthesis by first serving as an acceptor for the addition of 2 galactoses and 1 glucuronic acid residue to make the typical core structure, GlcUA beta 1, 3Gal beta 1,3Gal beta 1,4Xyl beta MU. To investigate the relative localization of these biosynthetic enzymes, intact and properly oriented rat liver Golgi preparations were incubated with Xyl beta MU and 1 microM UDP-[3H]Gal and then chased with 5 microM of unlabeled UDP-Gal, UDP-GlcUA, UDP-GlcNAc, UDP-GalNAc, and CMP-Neu5Ac. Under these conditions, no intervesicular transport occurs and acceptor labeling depends entirely upon transporter-mediated delivery of the labeled sugar nucleotides into the lumen of a vesicle and co-localization of the appropriate glycosyltransferases. The labeled products were isolated from the incubation medium and from within the Golgi and their structures analyzed by C18, anion-exchange, and amine adsorption high performance liquid chromatography in combination with glycosidase digestions. Surprisingly, the major products within the Golgi were two sialylated xylosides (Sia alpha 2,3Gal beta 1,4Xyl-beta MU and Sia alpha 2,8Sia alpha 2,3Gal beta 1,4Xyl beta MU) rather than the expected group of partially completed GAG core structures. Less than 10% of the products within the Golgi are the expected core structures containing a second Gal residue or, in addition, GlcUA. The amount of the sialylated products is only partially decreased if the chase is omitted or if the chase is done in the absence of added CMP-Sia, suggesting a pool of previously transported CMP-Sia drives synthesis of the major products. Conversely, when detergent permeabilized vesicles are provided with high concentration of the same sugar nucleotides, the ratio of sialylated products is reduced and replaced by an increase in GAG-like products. These results argue that GAG core-specific Ga1 transferase I and II are not extensively co-localized within the same Golgi compartment. By contrast, glycosaminoglycan core Gal transferase I is substantially co-localized with an alpha-2,3-sialyltransferase and an alpha-2,8-sialyltransferase. Incubating intact Golgi vesicles with exogenous diffusible acceptors offers a novel method to assess the functional co-localization of glycosyltransferases of multiple pathways within the Golgi compartments.
Asunto(s)
Glicosaminoglicanos/metabolismo , Glicosiltransferasas/metabolismo , Aparato de Golgi/enzimología , Hígado/enzimología , Sialiltransferasas/metabolismo , Animales , Transporte Biológico , Secuencia de Carbohidratos , Detergentes , Difusión , Glicósidos/metabolismo , Masculino , Datos de Secuencia Molecular , Oligosacáridos/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
Exogenous contamination poses a major problem to accurate determination of trace metals in biological samples. Analysis of these elements in biological material entails adoption of special precautionary measures. In this study we have assessed the various procedural steps of sampling and analysis of zinc in order to identify and minimize extraneous contamination in the laboratory. In addition we have established reference limits (2 SD) for zinc in human plasma, erythrocytes and hair.
Asunto(s)
Eritrocitos/química , Cabello/química , Zinc/análisis , Adolescente , Adulto , Femenino , Humanos , Masculino , Reproducibilidad de los Resultados , Zinc/sangreAsunto(s)
Glicoles de Etileno , Zinc/sangre , Estabilidad de Medicamentos , Humanos , Control de CalidadRESUMEN
Serum prolactin levels are determined in 116 schizophrenics and 120 control subjects. Values of prolactin levels of the patients are compared with the values of control of the same sex and age group. There is no significant difference between prolactin levels of controls and those with negative or positive symptoms of schizophrenia. Analysis, taking age into account, also does not show any significant difference between patients with positive or negative symptoms and controls. The relationship between nature of symptoms of schizophrenia and serum prolactin levels varies in different studies. The possible reasons for such variations are discussed.
Asunto(s)
Prolactina/sangre , Esquizofrenia/sangre , Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Psicología del EsquizofrénicoRESUMEN
1. Serum prolactin levels were measured in large cohorts of schizophrenic patients (67 males and 42 females) and normal subjects (78 males and 42 females). 2. There was no significant differences between the serum prolactin levels of patients and controls, except in the age group 15-29 years. There were no significant differences between the serum prolactin levels of males and females, either among the patients or the control subjects. 3. The rise in serum prolactin levels after the commencement of neuroleptic medication in the patients was greater in females than in males even though the female patients received neuroleptics at lower doses. 4. These data indicate that serum prolactin levels in unmedicated males and females are similar; however, the prolactin response to neuroleptic medication is greater in females than in males.